Cochlear (OC5) Stock Overview

Provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. More details

OC5 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	1/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 50.8% below our estimate of its fair value

Earnings are forecast to grow 22.28% per year

Risk Analysis

Volatile share price over the past 3 months compared to the Swiss market

Large one-off items impacting financial results

Profit margins (6.3%) are lower than last year (16.6%)

OC5 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW443,000 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

443,000 investors already sharing narratives

View all narratives

Cochlear Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cochlear
Historical stock prices
Current Share Price	AU$78.74
52 Week High	AU$0
52 Week Low	AU$0
Beta	0.27
1 Month Change	3.25%
3 Month Change	43.02%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	43.02%

Recent updates

Shareholder Returns

	OC5	CH Medical Equipment	CH Market
7D	-3.6%	-3.6%	-2.8%
1Y	n/a	-7.9%	11.4%

Return vs Industry: Insufficient data to determine how OC5 performed against the Swiss Medical Equipment industry.

Return vs Market: Insufficient data to determine how OC5 performed against the Swiss Market.

Price Volatility

Is OC5's price volatile compared to industry and market?
OC5 volatility
OC5 Average Weekly Movement	6.9%
Medical Equipment Industry Average Movement	3.6%
Market Average Movement	3.9%
10% most volatile stocks in CH Market	7.5%
10% least volatile stocks in CH Market	2.0%

Stable Share Price: OC5's share price has been volatile over the past 3 months compared to the Swiss market.

Volatility Over Time: Insufficient data to determine OC5's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1981	5,400	Dig Howitt	www.cochlear.com

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link.

Cochlear Limited Fundamentals Summary

How do Cochlear's earnings and revenue compare to its market cap?
OC5 fundamental statistics
Market cap	CHF 5.14b
Earnings (TTM)	CHF 86.28m
Revenue (TTM)	CHF 1.38b

59.6x

P/E Ratio

3.7x

P/S Ratio

Is OC5 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OC5 income statement (TTM)
Revenue	AU$2.35b
Cost of Revenue	AU$688.00m
Gross Profit	AU$1.66b
Other Expenses	AU$1.51b
Earnings	AU$147.30m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	2.25
Gross Margin	70.69%
Net Profit Margin	6.27%
Debt/Equity Ratio	0%

How did OC5 perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

153%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/14 20:49
End of Day Share Price	2026/09/11 00:00
Earnings	2026/06/30
Annual Earnings	2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cochlear Limited is covered by 26 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Saul Hadassin	Barrenjoey Markets Pty Limited
Stuart Roberts	Bell Potter
Elisabeth Decou Clive	Bernstein

Cochlear LimitedBRSE:OC5 Stock Report